Ryuji Ueno - Sucampo Pharmaceuticals Insider

Stakeholder Ryuji Ueno is not found or was disassociated from the entity Sucampo Pharmaceuticals Inc

If you believe Ryuji Ueno is a valid insider of Sucampo Pharmaceuticals Inc please let us know and we will check it out.

Other Suggestions

Did you try this?

Run Portfolio Backtesting Now
   

Portfolio Backtesting

Avoid under-diversification and over-optimization by backtesting your portfolios
Hide  View All  Next  Launch Portfolio Backtesting
Fix your portfolio
By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations when you add Sucampo Pharmaceuticals Inc to your portfolio

Top Management

Sucampo Pharmaceuticals Leadership Team
Barbara Munder, Director, MBA
Peter Pfreundschuh, CFO, MBA
Matthew Donley, EVP
Max Donley, President
Peter Kiener, Executive, Ph.D
Matthias Alder, President
Daniel Getman, Chairman, Ph.D
Peter Greenleaf, Chairman, MBA
Silvia Taylor, President, MBA
Peter Lichtlen, Executive, Ph.D
Stanley Miele, President
William Ashton, Director
Andrew Smith, Executive
Timothy Walbert, Director
John Johnson, Director
Paul Edick, Director
Alex Driggs, Executive
Karen Smith, Director, MBA
Robert Spiegel, Director
Anthony Celeste, Director
Maureen OConnell, Director
Kei Tolliver, Director
Thomas Knapp, President

Stock Performance

Sucampo Pharmaceuticals Performance Indicators